Motor Symptom Relief and Medication Reduction with Bilateral STN-DBS in Parkinson’s Disease: A Five-Year Experience from a Tertiary Neurosurgery Center

Authors

  • Umer Mujtaba Meyo Hospital Lahore, Pakistan. Author
  • Imran Tahir Meyo Hospital Lahore, Pakistan. Author

DOI:

https://doi.org/10.65761/pjcr.2024.1.1.13

Keywords:

Parkinson’s disease, deep brain stimulation, STN-DBS, motor symptoms, medication reduction

Abstract

To determine the effectiveness of bilateral Subthalamic Nucleus Deep Brain Simulation (DBS) on relieving motor symptoms and reducing the use of medication in patients with Parkinson’s disease (PD) in this country setting. This cohort study was carried out in the Department of Neurosurgery at the Punjab Institute of Neurosciences, Lahore, between January 2018 and January 2023. Seventy-three patients who received bilateral STN-DBS and fulfilled the required criteria were part of the study. Participants were interviewed and clinical data were also collected. The key results were changes in LEDD and in motor function, as measured by the UPDRS parts III and IV. Analysis was run using data to measure if using STN-DBS lessened the amount of medicine patients took and improved their motor symptoms. As a result of bilateral STN-DBS, there was a significant decrease in LEDD by 55.03% (p < 0.0001) and a large improvement in UPDRS-III scores by 80.49% (p < 0.0001). Despite the UPDRS-IV not improving much by 1% and not being significant statistically (p = 0.2751), the reduction in time with dyskinesia (17.54%) and off periods (22.44%) was visible, suggesting that motor complications were better controlled. Fitted with bilateral STN-DBS, many patients with early- to moderate-stage Parkinson’s disease get good results in countries where resources are scarce. Many people require less Dopamine-based medication and their symptoms of rigidity, tremors and Bradykinesia are greatly reduced. The results back up using STN-DBS as a routine treatment for people with PD in developing countries, helping to raise their well-being and treatment outcomes.

References

1. Alameer, A. A. H., Alhuraysi, M. A. M., Alhazmi, M. I., Al-Ghamdi, W. A. M., Alshehri, S. A. A., Maashi, S. M., & Al- Ghashmari, K. H. A. (2024). Parkinson Disease: An Overview for the Management Techniques Via Physical Therapy. Journal of Ecohumanism, 3(8), 12698-12707.

2. Lee, J. H. (2023). Understanding Parkinson's Disorders: Classification and Evaluation Methods, Movement Disorders, and Treatment Methods. International Journal of Advanced Culture Technology, 11(3), 9-17.

3. di Biase, L., Pecoraro, P. M., Carbone, S. P., Caminiti, M. L., & Di Lazzaro, V. (2023). Levodopa-induced dyskinesias in Parkinson’s disease: an overview on pathophysiology, clinical manifestations, therapy management strategies and future directions. Journal of Clinical Medicine, 12(13), 4427.

4. Bhidayasiri, R., Phuenpathom, W., Tan, A. H., Leta, V., Phumphid, S., Chaudhuri, K. R., & Pal, P. K. (2022). Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice– Balancing pharmacological and non-pharmacological approaches. Frontiers in aging neuroscience, 14, 979826.

5. Malvea, A., Babaei, F., Boulay, C., Sachs, A., & Park, J. (2022). Deep brain stimulation for Parkinson’s disease: a review and future outlook. Biomedical engineering letters, 12(3), 303-316.

6. Olson, M. C., Shill, H., Ponce, F., & Aslam, S. (2023). Deep brain stimulation in PD: risk of complications, morbidity, and hospitalizations: a systematic review. Frontiers in Aging Neuroscience, 15, 1258190.

7. Davidson, B., Milosevic, L., Kondrataviciute, L., Kalia, L. V., & Kalia, S. K. (2024). Neuroscience fundamentals relevant to neuromodulation: neurobiology of deep brain stimulation in Parkinson's disease. Neurotherapeutics, 21(3), e00348.

8. Zhu, K., Peng, S., Wu, Y., Zhao, Y., & Lu, Z. (2023). Deep brain stimulation of the subthalamic nucleus improves sleep in Parkinson disease patients: A systematic review and meta-analysis. Medicine, 102(32), e34509.

9. Hariz, M., & Blomstedt, P. (2022). Deep brain stimulation for Parkinson's disease. Journal of internal medicine, 292(5), 764-778.

10. Xu, W., Wang, J., Li, X. N., Liang, J., Song, L., Wu, Y., ... & Li, W. G. (2023). Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease. Translational Neurodegeneration, 12(1), 55.

11. Davidson, B., Milosevic, L., Kondrataviciute, L., Kalia, L. V., & Kalia, S. K. (2024). Neuroscience fundamentals relevant to neuromodulation: neurobiology of deep brain stimulation in Parkinson's disease. Neurotherapeutics, 21(3), e00348.

12. Xu, W., Wang, J., Li, X. N., Liang, J., Song, L., Wu, Y., ... &

Li, W. G. (2023). Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease. Translational Neurodegeneration, 12(1), 55.

13. Barbosa, R. M. G., Soares, M. C., Portela, D. M. M. C., Guimarães, T. G., & Cury, R. G. (2024). New perspectives of deep brain stimulation indications for Parkinson’s disease: A critical review. Brain Sciences, 14(7), 638.

14. Onder, H., & Comoglu, S. (2024). Investigation of the nonmotor symptoms in patients with STN-DBS therapy in comparison with those without STN-DBS. Journal of Neural Transmission, 131(8), 931-940.

15. Kremer, N. I., van Laar, T., Lange, S. F., Muller, S. S., La Bastide-van Gemert, S., Oterdoom, D. M., ... & van Dijk, J. M. C. (2023). STN-DBS electrode placement accuracy and motor improvement in Parkinson’s disease: systematic review and individual patient meta- analysis. Journal of Neurology, Neurosurgery & Psychiatry, 94(3), 236-244.

16. Pal, G., Corcos, D. M., Metman, L. V., Israel, Z., Bergman, H., & Arkadir, D. (2023). Gaps and Controversies: Cognitive Effects of STN-DBS in Parkinson’s disease with GBA1 pathogenic variants. Movement disorders: official journal of the Movement Disorder Society, 38(12), 2155.

17. Lees, A., Tolosa, E., Stocchi, F., Ferreira, J. J., Rascol, O., Antonini, A., & Poewe, W. (2023). Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach. Expert Review of Neurotherapeutics, 23(1), 15-24.

18. Memon, A. A., Gelman, K., Melott, J., Billings, R., Fullard, M., Catiul, C., ... & Amara, A. W. (2023). A systematic review of health disparities research in deep brain stimulation surgery for Parkinson’s disease. Frontiers in Human Neuroscience, 17, 1269401.

Downloads

Published

2024-12-31

How to Cite

1.
Mujtaba U, Tahir I. Motor Symptom Relief and Medication Reduction with Bilateral STN-DBS in Parkinson’s Disease: A Five-Year Experience from a Tertiary Neurosurgery Center. Pak J Clin Res [Internet]. 2024 Dec. 31 [cited 2026 Feb. 24];1(1):18-21. Available from: https://pjcr.org/index.php/PJCR/article/view/13